Update: MHRA issues new restrictions and precautions for Fluoroquinolone antibiotics | 28 March 2019
Dr Shepherd provides an update on warnings about a particular group of antibiotics and talks about antibiotic use in general.
Dr Shepherd provides an update on warnings about a particular group of antibiotics and talks about antibiotic use in general.
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019 Read More »
Latest research analysis is hoped will lead to a definitive definition and will ultimately provide a validated clinical assessment tool.
Go BLUE for ME in ME Awareness Week: New ME Association T-Shirts! | 20 March 2019 Read More »
Introducing our new Go BLUE for ME T-Shirts. Help raise awareness and raise funds during ME Awareness Week.
Dr Francis Ryan, writing for The Guardian, on how recent media reporting has contributed to the vilification of disabled people.
New prescribing controls come into force for pain relieving drugs | 19 March 2019 Read More »
Gabapentin and Pregabalin considered controlled substances and prescriptions will be restricted.
Referral to a haematologist finally confirmed his chronic fatigue was a symptom of haemochromatosis.
Abnormalities in energy production would seem to occur ‘upstream’ of the mitochondria.
Fundraising: Andy’s Charity Day for M.E. | 08 March 2019 Read More »
“It’s going to be an amazing day of music, but a hugely emotional one too – given Andy’s strong connection to our charity.”
ME Association February Summary of ME/CFS Published Research | 06 March 2019 Read More »
We’ve updated our central Research Index and feature 18 research abstracts from February 2019.
This month we are asking for your feedback to help Dr Shepherd prepare a new leaflet.
ME Awareness Week 2019 will be all about YOU and M.E! | 04 March 2019 Read More »
Our focus this year will be the Real M.E. but we’ll also be helping you Go BLUE and raise awareness.
“I began the month worried about what I would post but it evolved nicely and the support came rolling in.”